The Biomaterials Access Assurance Act (“BAAA”), 21 U.S.C. § 1602(1)(A) immunized defendant, the manufacturer of a portion of a hip replacement prosthesis from liability that arose when a portion of the prosthesis supplied by defendant broke after implantation, requiring a new surgery and replacement. The act provides immunity for those supplying parts of a human implant.